1.
Secondary rise in blood pressure after renal denervation
by Vonend, Oliver, MD
The Lancet (British edition), 2012, Vol.380 (9843), p.778-778
2.
Renal Hemodynamics and Renal Function After Catheter-Based Renal Sympathetic Denervation in Patients With Resistant Hypertension
by Mahfoud, Felix
Hypertension (Dallas, Tex. 1979), 2012-08, Vol.60 (2), p.419-424
3.
The Adrenal Vein Sampling International Study (AVIS) for Identifying the Major Subtypes of Primary Aldosteronism
by Rossi, Gian Paolo
The journal of clinical endocrinology and metabolism, 2012-05, Vol.97 (5), p.1606-1614
4.
Angiotensin-(1-7)-induced Mas receptor activation attenuates atherosclerosis through a nitric oxide-dependent mechanism in apolipoproteinE-KO mice
by Yang, Guang
Pflügers Archiv, 2018-01-20, Vol.470 (4), p.661-667
5.
Coadministration of valsartan 160 and 320 mg and simvastatin 20 and 40 mg in patients with hypertension and hypercholesterolemia: A multicenter, 12-week, double-blind, double-dummy...
by Rump, Lars-Christian, MD
Clinical therapeutics, 2008, Vol.30 (10), p.1782-1793
6.
Vitamin D and cinacalcet administration pre-transplantation predict hypercalcaemic hyperparathyroidism post-transplantation: a case-control study of 355 deceased-donor renal transp...
by Tillmann, Frank-Peter
Transplantation research, 2014, Vol.3 (1), p.21-21
7.
Obstructive sleep apnea and blood pressure: Interaction between the blood pressure-lowering effects of positive airway pressure therapy and antihypertensive drugs
by BÖRGEL, Jan
American journal of hypertension, 2004, Vol.17 (12), p.1081-1087
8.
Obstructive sleep apnea and blood pressure
by Börgel, Jan
American journal of hypertension, 2004, Vol.17 (12), p.1081-1087
9.
alpha-Adrenoceptor Modulation of Norepinephrine and ATP Release in Isolated Kidneys of Spontaneously Hypertensive Rats
by Bohmann, Christine
Hypertension (Dallas, Tex. 1979), 1995-06, Vol.25 (6), p.1224-1231
10.
Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months
by Symplicity HTN-1 Investigators
Hypertension (Dallas, Tex. 1979), 2011-05, Vol.57 (5), p.911-917
11.
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
by Esler, Murray D
The Lancet (British edition), 2010, Vol.376 (9756), p.1903-1909
12.
Adrenal venous sampling: evaluation of the German Conn's registry
by Vonend, Oliver
Hypertension (Dallas, Tex. 1979), 2011-05, Vol.57 (5), p.990-995
13.
Risk Factors Associated with a Low Glomerular Filtration Rate in Primary Aldosteronism
by Reincke, Martin
The journal of clinical endocrinology and metabolism, 2009-03, Vol.94 (3), p.869-875
14.
Experimental evidence to support ELITE
by Rump, Lars Christian
The Lancet (British edition), 1998, Vol.351 (9103), p.644-645
15.
Negative feedback regulation within NO/cGMP pathway attenuates vasodilatory response in renovascular hypertension
by Mergia, Evanthia
BMC pharmacology, 2009-08-11, Vol.9 (S1), p.P48-P48
16.
Catheter-Based Renal Nerve Ablation and Centrally Generated Sympathetic Activity in Difficult-to-Control Hypertensive Patients: Prospective Case Series
by Mahfoud, Felix
Hypertension (Dallas, Tex. 1979), 2013-02, Vol.61 (2), p.e17-e17
17.
Abstract 1: Deletion of the Mapk-p38 From Vascular Smooth Muscle Cells and Cardiomyocytes Causes Hypotension and Dilated Cardiomyopathy in Angiotensin II Dependent Hypertension
by Mende, Susanne
Hypertension (Dallas, Tex. 1979), 2013-09, Vol.62 (suppl_1)
18.
A Tale of Two Patients With Mendelian Hypertension
by Quack, Ivo
Hypertension (Dallas, Tex. 1979), 2008-03, Vol.51 (3), p.609-614
19.
A re-investigation of questionable subclassifications of presynaptic α2-autoreceptors: rat vena cava, rat atria, human kidney and guinea-pig urethra
by Trendelenburg, A.-U.
Naunyn-Schmiedeberg's archives of pharmacology, 1997-12-02, Vol.356 (6), p.721-737
